Boston Scientific Corp. (BSX)

Index:

$ 74.97

By Michele Maatouk

Date: Thursday 15 Jan 2026

(Sharecast News) - Boston Scientific said on Thursday that it has agreed to buy thrombectomy company Penumbra in a $14.5bn deal.

Boston Scientific posts mixed Q4 numbers amid cu...	01-Feb-2023	ShareCast
Boston Scientific to buy Baylis Medical for $1.7...	06-Oct-2021	ShareCast
BTG gets US clearance for proposed ?3.3bn Boston...	07-Aug-2019	ShareCast
Boston Scientific misses first-quarter targets	24-Apr-2019	ShareCast
BTG rockets on Boston Scientific deal	20-Nov-2018	ShareCast

Boston Scientific Posts Profit, but Weak Outlook	20-Oct-2009	New York Times
Profit at Boston Scientific Grows 61% as Sales R...	21-Jul-2009	New York Times
Inquiry Into Medtronic’s Marketing	05-Mar-2009	New York Times
Johnson & Johnson Receives Subpoena on Bile Duct...	05-Aug-2008	New York Times
Financier Stands by a Firm Tainted by Heparin	23-May-2008	New York Times

Market movers	26-Feb-2008	Chicago Tribune
Abbott falls behind in stents race	01-Sep-2007	Chicago Tribune
Rumors of rate cut lift stocks	17-Aug-2007	LA Times
Stent studies buoy Abbott	23-May-2007	Chicago Tribune
Johnson & Johnson's heart stent fails trial, der...	08-May-2007	Intl Herald Tribune

38 Cryoablation Studies, Exhibits Presented at N...	02-Dec-2008	PR Newswire
Cardiogenesis Announces Addition of Raymond W. C...	02-Dec-2008	PR Newswire
Boston Scientific to Participate in Piper Jaffra...	24-Nov-2008	PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.